Revenue
2.57 million Unit_Standard_USD_hX9lgLnmjk-YVs77K498VA
2025 Q1 · Unit_Standard_USD_hX9lgLnmjk-YVs77K498VA
Exact inputs and evidence
- Revenue: 2569000 Unit_Standard_USD_hX9lgLnmjk-YVs77K498VA Source
Fundies. English
Cara Therapeutics, Inc.
EDGARAnnual consolidated revenue for 2024: about Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 7.137M, using the latest reported figures. The previous period, 2023, was about Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 20.97M.
Latest quarter
- Cash and cash equivalents
- 15.8 million Unit_Standard_USD_4GdLVEcwY0aqMvod41nVjA Source
Exact value
15800000 Unit_Standard_USD_4GdLVEcwY0aqMvod41nVjA
- Long-term debt including current maturities
- 28.3 million Unit_Standard_USD_QYdKXPVCSkeyITONlcpppQ Source
Exact value
28298000 Unit_Standard_USD_QYdKXPVCSkeyITONlcpppQ
- Shares outstanding
- 9.38 million Unit_Standard_shares_p-t9PjGV7USly7mdI6CBcQ Source
Exact value
9381344 Unit_Standard_shares_p-t9PjGV7USly7mdI6CBcQ
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-14.
Financial data available through: 2024-12-31.
Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.
Coverage by financial measure
- Revenue: 3 of 11 periods available· newest 2024-12-31
- Operating income: Multiple units; comparison withheld· newest 2024-12-31
- Net income: Multiple units; comparison withheld· newest 2024-12-31
- Operating cash flow: Multiple units; comparison withheld· newest 2024-12-31
- Capital expenditure: 3 of 11 periods available· newest 2024-12-31
- Total assets: Multiple units; comparison withheld· newest 2024-12-31
- Total liabilities: Multiple units; comparison withheld· newest 2024-12-31
- Current assets: Multiple units; comparison withheld· newest 2024-12-31
- Current liabilities: Multiple units; comparison withheld· newest 2024-12-31
- Cash and cash equivalents: Multiple units; comparison withheld· newest 2024-12-31
- Long-term debt including current maturities: 1 of 11 periods available· newest 2024-12-31
- Shares outstanding: Multiple units; comparison withheld· newest 2024-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
-66%Prior period
Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 20.97 million
–
Current period
Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 7.14 million
–
Exact inputs and evidence
7137000 − 20968000 = -13831000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw
20968000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw · 2023-01-01 – 2023-12-31
Inspect prior input Prior source7137000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw · 2024-01-01 – 2024-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 47.65 millionPrior period
−Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 118.51 million
–
Current period
−Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 70.87 million
–
Exact inputs and evidence
-70867000 − -118513000 = 47646000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw
-118513000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw · 2023-01-01 – 2023-12-31
Inspect prior input Prior source-70867000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw · 2024-01-01 – 2024-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 31.16 millionPrior period
−Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 92.08 million
–
Current period
−Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 60.92 million
–
Exact inputs and evidence
-60917000 − -92078000 = 31161000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw
-92078000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw · 2023-01-01 – 2023-12-31
Inspect prior input Prior source-60917000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw · 2024-01-01 – 2024-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-56%Prior period
Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 2.38 million
–
Current period
Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 1.05 million
–
Exact inputs and evidence
1046000 − 2375000 = -1329000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw
2375000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw · 2023-01-01 – 2023-12-31
Inspect prior input Prior source1046000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw · 2024-01-01 – 2024-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2024 2024-01-01 – 2024-12-31
- Revenue Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 7.14 million 100% of revenue
- Operating costs Derived Unavailable An input is unavailable.
- Operating income Unavailable An input is unavailable.
- Tax, interest and other Derived Unavailable An input is unavailable.
- Net income Unavailable An input is unavailable.
Cash
- Operating cash flow Unavailable An input is unavailable.
- Capital expenditure Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 1.05 million 15% of revenue
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2022 Not shown: operating income or net income is not reported.
- 2023 Not shown: operating income or net income is not reported.
- 2024 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | 41867000 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 20968000 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 7137000 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Source
|
Amounts are exact, in Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 7.1M 2024
Values and sources
| Period | Series | Value(Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw) | Source evidence |
|---|---|---|---|
| 2022 | Revenue | 41867000 |
|
| 2023 | Revenue | 20968000 |
|
| 2024 | Revenue | 7137000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
-66% 2024
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | -49.9% |
|
| 2024 | Year over year | -66% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022-12-31 | Operating margin | Not reported |
|
| 2023-12-31 | Operating margin | Not reported |
|
| 2024-12-31 | Operating margin | Not reported |
|
| 2022-12-31 | Net margin | Not reported |
|
| 2023-12-31 | Net margin | Not reported |
|
| 2024-12-31 | Net margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw) | Source evidence |
|---|---|---|---|
| 2022 | Operating cash flow | Not reported | No source recorded |
| 2023 | Operating cash flow | Not reported | No source recorded |
| 2024 | Operating cash flow | Not reported | No source recorded |
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw) | Source evidence |
|---|---|---|---|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2023-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2024-12-31 | Liabilities / assets | Not reported | No source recorded |
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2023-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2024-12-31 | Current assets / current liabilities | Not reported | No source recorded |
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 43,000 Exact valueExact value: 43000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 2022-01-01 – 2022-12-31: 43000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw Inspect Capital Expenditure Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 2.38 million Exact valueExact value: 2375000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 2023-01-01 – 2023-12-31: 2375000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw Inspect Capital Expenditure Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 1.05 million Exact valueExact value: 1046000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw 2024-01-01 – 2024-12-31: 1046000 Unit_Standard_USD_mqyMhMKZ-Ue8iQ1GmtrmMw Inspect Capital Expenditure Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
62 filings · 5,222 latest values · 5,222 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001346830, 1346830, CARA, TVRD, edgar:1346830
Also known as CARA THERAPEUTICS, INC., CARA THERAPEUTICS, INC., Cara Therapeutics Inc, Cara Therapeutics, Inc., TVARDI THERAPEUTICS, INC., TVARDI THERAPEUTICS, INC., Tvardi Therapeutics, Inc.